ALPHA-1062

FDA approves Alpha Cognition's Zunveyl for mild-to-moderate Alzheimer disease
Neurology Live
Mon, 07/29/24 - 10:58 am
Alpha Cognition
FDA
Zunveyl
ALPHA-1062
Alzheimer's disease